About 4C LABS
4C LABS is a rapidly scaling healthcare, technology and pharmaceutical start-up focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis based medicinal products for human health. The empirical evidence for the efficacy of CBPM's as a therapeutic agent in the treatment of cancer related pain, anxiety, childhood epilepsy, spasticity and sleep disorders is now overwhelming. We are committed to advancing scientific research, as well as enabling the regulation, distribution and prescribing of CBPM's in the UK and Channel Islands. Our work with leading scientists, specialist physicians and pharmacists is underpinned with disruptive technologies that are driving an approach to treatment that prioritizes patients and evidence over stigma. We work closely with Drug Science, the Cannabis Industry Council, The Home Office, The Medicines and Healthcare and regulatory Authority and the Care Quality Commission to catalyse safe, regulated change in the medical landscape. If you are a technologist, physician, scientist, distributor, LP or a patient and are interested in working with us, get in touch for a conversation: info@4clabs.ca
- Founded
- 2018
- Employees
- 125
- Headquarters
- London
Leadership
The top of 4C LABS's org chart, with how many people report into each leader.
Greg Dobbin
Chief Executive Officer
10 reports
Elisabetta Faenza
Head of Quality
3 reports
James Smith
Chief Revenue Officer (cro)
2 reports
Sam Heath
Operations Manager
1 report
Grant Koehler
Advisor, Medical Business
Jobs at 4C LABS
No open positions right now. Explore more companies on TheJobsMap.